Australian researcher David Geoffrey Chapman has been awarded $100,000 by the American Thoracic Society (ATS) Foundation and ResMed…
Alberto Molano, PhD
Alberto Molano was born in Bogotá, Colombia. He studied medicine at Universidad del Rosario and obtained a Ph.D. in Immunology from Weill Cornell Graduate School of Medical Sciences in New York. He conducted research and authored or co-authored twenty publications on molecular and cellular immunology, autoimmunity, immunology of aging and parasite immunology.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Alberto Molano, PhD
Piedmont Atlanta announced that it is the first hospital in the state of Georgia to offer treatment for emphysema…
Azithromycin treatment initiated during hospitalization for an acute exacerbation of chronic obstructive pulmonary disease (COPD), followed by three months of…
Canadian wellness app Carrot Rewards has announced a new campaign in collaboration with The Lung Association — Ontario and…
Circassia announced that the U.S. Food and Drug Administration (FDA) approved its medication Duaklir for the maintenance treatment…
A relatively new non-invasive imaging technique, called parametric response mapping (PRM), can identify damage in the smallest airways, opening the…
Nuvaira, a medical device company, announced it has secured $79 million to support the AIRFLOW-3 clinical trial to assess…
The U.S. Food and Drug Administration has approved Olympus‘ Spiration Valve System (SVS)Â as a minimally invasive treatment for…
Chronic obstructive pulmonary disease (COPD) is much more common in obese individuals ages 50 and older who have never…